Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Insight Venture Partners on their investment by participation in a EUR 56 000 000 investment round in Tink AB.
Mandate

Vinge advises Insight Venture Partners on their investment by participation in a EUR 56 000 000 investment round in Tink AB.

February 11, 2019 M&A

Founded in Stockholm in 2012, Tink AB is a cloud-based platform that provides the infrastructure and value-adding data products that are enabling the future of financial services.

Tink’s products can be used to develop standalone services or be integrated into existing banking applications. 

Insight Venture Partners is a leading global venture capital and private equity firm investing in high-growth technology and software companies that are driving transformative change in their industries.

Vinge’s team consisted of Christina Kokko, Ulrich Ziche, Michaela Cronemyr, Isabelle Jengsell (M&A), Malin Haag, Stina Bengtsson (Financial Services), Sara Strandberg (Employment), Nicklas Thorgerzon (IT/GDPR), Arvid Axelryd (Commercial Agreements), Lisa Hörnqvist (IP) and Frida Ställborn (Real Property).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026